Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Blood Plasma Derivatives Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Blood Plasma Derivatives Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Albumin
      • 1.3.3 Factor VIII
      • 1.3.4 Factor IX
      • 1.3.5 Immunoglobulin
      • 1.3.6 Hyperimmune Globulin
      • 1.3.7 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Blood Plasma Derivatives Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Other End Users
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Blood Plasma Derivatives Production Value 2014-2025
      • 2.1.2 Global Blood Plasma Derivatives Production 2014-2025
      • 2.1.3 Global Blood Plasma Derivatives Capacity 2014-2025
      • 2.1.4 Global Blood Plasma Derivatives Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Blood Plasma Derivatives Market Size CAGR of Key Regions
      • 2.2.2 Global Blood Plasma Derivatives Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Blood Plasma Derivatives Capacity by Manufacturers
      • 3.1.2 Global Blood Plasma Derivatives Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Blood Plasma Derivatives Revenue by Manufacturers (2014-2019)
      • 3.2.2 Blood Plasma Derivatives Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI)
    • 3.3 Blood Plasma Derivatives Price by Manufacturers
    • 3.4 Key Manufacturers Blood Plasma Derivatives Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Blood Plasma Derivatives Market
    • 3.6 Key Manufacturers Blood Plasma Derivatives Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Albumin Production and Production Value (2014-2019)
      • 4.1.2 Factor VIII Production and Production Value (2014-2019)
      • 4.1.3 Factor IX Production and Production Value (2014-2019)
      • 4.1.4 Immunoglobulin Production and Production Value (2014-2019)
      • 4.1.5 Hyperimmune Globulin Production and Production Value (2014-2019)
      • 4.1.6 Others Production and Production Value (2014-2019)
    • 4.2 Global Blood Plasma Derivatives Production Market Share by Type
    • 4.3 Global Blood Plasma Derivatives Production Value Market Share by Type
    • 4.4 Blood Plasma Derivatives Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Blood Plasma Derivatives Consumption by Application

    6 Production by Regions

    • 6.1 Global Blood Plasma Derivatives Production (History Data) by Regions 2014-2019
    • 6.2 Global Blood Plasma Derivatives Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Blood Plasma Derivatives Production Growth Rate 2014-2019
      • 6.3.2 United States Blood Plasma Derivatives Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Blood Plasma Derivatives Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Blood Plasma Derivatives Production Growth Rate 2014-2019
      • 6.4.2 European Union Blood Plasma Derivatives Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Blood Plasma Derivatives Import & Export
    • 6.5 China
      • 6.5.1 China Blood Plasma Derivatives Production Growth Rate 2014-2019
      • 6.5.2 China Blood Plasma Derivatives Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Blood Plasma Derivatives Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Blood Plasma Derivatives Consumption by Regions

    • 7.1 Global Blood Plasma Derivatives Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Blood Plasma Derivatives Consumption by Type
      • 7.2.2 United States Blood Plasma Derivatives Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Blood Plasma Derivatives Consumption by Type
      • 7.3.2 European Union Blood Plasma Derivatives Consumption by Application
    • 7.4 China
      • 7.4.1 China Blood Plasma Derivatives Consumption by Type
      • 7.4.2 China Blood Plasma Derivatives Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Blood Plasma Derivatives Consumption by Type
      • 7.5.2 Rest of World Blood Plasma Derivatives Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Grifols
      • 8.1.1 Grifols Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Blood Plasma Derivatives
      • 8.1.4 Blood Plasma Derivatives Product Introduction
      • 8.1.5 Grifols Recent Development
    • 8.2 SK Plasma
      • 8.2.1 SK Plasma Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Blood Plasma Derivatives
      • 8.2.4 Blood Plasma Derivatives Product Introduction
      • 8.2.5 SK Plasma Recent Development
    • 8.3 Fusion Health Care
      • 8.3.1 Fusion Health Care Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Blood Plasma Derivatives
      • 8.3.4 Blood Plasma Derivatives Product Introduction
      • 8.3.5 Fusion Health Care Recent Development
    • 8.4 Biotest AG
      • 8.4.1 Biotest AG Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Blood Plasma Derivatives
      • 8.4.4 Blood Plasma Derivatives Product Introduction
      • 8.4.5 Biotest AG Recent Development
    • 8.5 Green Cross Corporation
      • 8.5.1 Green Cross Corporation Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Blood Plasma Derivatives
      • 8.5.4 Blood Plasma Derivatives Product Introduction
      • 8.5.5 Green Cross Corporation Recent Development
    • 8.6 Baxter International
      • 8.6.1 Baxter International Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Blood Plasma Derivatives
      • 8.6.4 Blood Plasma Derivatives Product Introduction
      • 8.6.5 Baxter International Recent Development
    • 8.7 LFB
      • 8.7.1 LFB Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Blood Plasma Derivatives
      • 8.7.4 Blood Plasma Derivatives Product Introduction
      • 8.7.5 LFB Recent Development
    • 8.8 Octapharma AG
      • 8.8.1 Octapharma AG Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Blood Plasma Derivatives
      • 8.8.4 Blood Plasma Derivatives Product Introduction
      • 8.8.5 Octapharma AG Recent Development
    • 8.9 CSL Limited
      • 8.9.1 CSL Limited Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Blood Plasma Derivatives
      • 8.9.4 Blood Plasma Derivatives Product Introduction
      • 8.9.5 CSL Limited Recent Development
    • 8.10 Shire Plc.
      • 8.10.1 Shire Plc. Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Blood Plasma Derivatives
      • 8.10.4 Blood Plasma Derivatives Product Introduction
      • 8.10.5 Shire Plc. Recent Development
    • 8.11 China Biologic Products
    • 8.12 Kedrion Biopharma
    • 8.13 BDI Pharma
    • 8.14 Bayer AG
    • 8.15 Hualan Biological Engineering

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Blood Plasma Derivatives Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Blood Plasma Derivatives Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Blood Plasma Derivatives Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Blood Plasma Derivatives Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Blood Plasma Derivatives Production Forecast by Type
      • 9.7.2 Global Blood Plasma Derivatives Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Blood Plasma Derivatives Sales Channels
      • 10.2.2 Blood Plasma Derivatives Distributors
    • 10.3 Blood Plasma Derivatives Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
      The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.
      In 2019, the market size of Blood Plasma Derivatives is 24800 million US$ and it will reach 52000 million US$ in 2025, growing at a CAGR of 9.7% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Blood Plasma Derivatives.

      This report studies the global market size of Blood Plasma Derivatives, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Blood Plasma Derivatives production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Grifols
      SK Plasma
      Fusion Health Care
      Biotest AG
      Green Cross Corporation
      Baxter International
      LFB
      Octapharma AG
      CSL Limited
      Shire Plc.
      China Biologic Products
      Kedrion Biopharma
      BDI Pharma
      Bayer AG
      Hualan Biological Engineering

      Market Segment by Product Type
      Albumin
      Factor VIII
      Factor IX
      Immunoglobulin
      Hyperimmune Globulin
      Others

      Market Segment by Application
      Hospitals
      Clinics
      Other End Users

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Blood Plasma Derivatives status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Blood Plasma Derivatives manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Blood Plasma Derivatives are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now